한글목차

세계의 알레르기 치료 시장은 2025년에 227억 6,000만 달러로 추정되며, 2032년에는 375억 4,000만 달러에 달할 것으로 예측되며, 2025-2032년 연간 평균 성장률(CAGR)은 7.4%로 성장할 전망입니다.

도표. 2025년 지역별 알레르기 치료 시장 점유율(%)

세계 알레르기 치료 시장은 전 세계 알레르기 질환의 유병률 증가로 인해 지난 수년간 큰 성장세를 보이고 있습니다. 알레르기 질환은 먼지, 꽃가루, 곰팡이와 같은 환경 알레르겐에 대한 면역체계의 과민반응으로 인해 발생합니다. 최근 추정에 따르면 전 세계 10억 명 이상이 알레르기성 비염을 앓고 있는 것으로 나타났습니다. 또한 오염 수준 증가와 생활 습관의 변화로 인해 알레르기 발병의 위험은 더욱 증가하고 있습니다. 이에 따라 항히스타민제, 충혈제거제, 코르티코스테로이드, 알레르겐 면역 요법 등 다양한 알레르기 증상을 관리할 수 있는 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다.

시장 역학

세계 알레르기 치료 시장은 오염 수준 증가, 기후 변화, 신흥 국가의 의료비 지출 증가 등의 요인에 의해 주도되고 있습니다. 그러나 농촌 지역에서 알레르기 치료에 대한 인식이 낮고 면역치료에 대한 높은 비용이 시장 성장을 저해하는 요인으로 작용하고 있습니다. 효능이 개선된 새로운 치료법의 개발은 시장에 유리한 기회를 제공합니다. 주요 기업은 약물 내성 문제를 해결하기 위한 첨단 치료 요법을 개발하기 위해 연구개발에 집중하고 있습니다. 그러나 새로운 알레르기 치료제의 승인에 대한 엄격한 규제가 과제로 작용하고 있습니다.

본 조사의 주요 특징

• 세계의 알레르기 치료 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR%)을 게재하고 있습니다.
• 또한 다양한 부문에 걸친 잠재적인 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 세계 알레르기 치료제 시장의 주요 기업 개요을 기업 개요, 제품 포트폴리오, 주요 특징, 실적, 전략 등의 파라미터를 기준으로 정리하여 수록했습니다.
• 주요 기업에는 Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, Dr Reddy's Laboratories Ltd. 등이 있습니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 알레르기 치료 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 알레르기 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• COM(Coherent Opportunity Map)(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 역학
• 규제 시나리오
• 제조업체 매출
• 인수와 제휴 시나리오
• 제품 발매/승인
• 자금조달과 투자
• PEST 분석
• Porter의 산업 분석

제4장 세계의 알레르기 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 알레르기 치료 시장, 유형별, 2020-2032년(10억 달러)

• 서론
• 눈 알레르기
• 천식
• 비염
• 피부 알레르기
• 식품 알레르기
• 기타

제6장 세계의 알레르기 치료 시장, 치료법별, 2020-2032년(10억 달러)

• 서론
• 항알레르기약
• 면역치료

제7장 세계의 알레르기 치료 시장, 유통 채널별, 2020-2032년(10억 달러)

• 서론
• 병원 약국
• 소매 약국
• 온라인 약국

제8장 세계의 알레르기 치료 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Sanofi
  • Novartis
  • GSK plc
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Stallergenes Greer
  • Dermapharm Holding SE
  • Nicox
  • Allergy Therapeutics
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Alembic Pharmaceuticals Limited
  • ALK-Abello A/S
  • Bausch Health Companies Inc.
  • GLENMARK PHARMACEUTICALS LTD.
  • Perrigo Company plc
  • Dr Reddy's Laboratories Ltd.

제10장 애널리스트의 시점

• 운명의 수레바퀴
• COM(Coherent Opportunity Map)

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Allergy Treatment Market is estimated to be valued at USD 22.76 Bn in 2025 and is expected to reach USD 37.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Figure. Allergy Treatment Market Share (%), By Region 2025

The global allergy treatment market has been witnessing significant growth over the past few years owing to the rising prevalence of allergic disorders worldwide. Allergic disorders are caused when the immune system overreacts to environmental allergens such as dust, pollen, mold, etc. According to recent estimates, over 1 billion people globally suffer from allergic rhinitis. Additionally, the rising levels of pollution and changed lifestyle habits have further increased the risk of developing allergies. As a result, there has been a growing demand for effective treatment options such as antihistamines, decongestants, corticosteroids, and allergen immunotherapy for managing the symptoms of various allergic conditions.

Market Dynamics:

The global allergy treatment market is driven by factors such as increasing pollution levels, changing climate conditions, and rising healthcare expenditure in developing nations. However, the lack of awareness about allergy treatment in rural areas and high costs associated with immunotherapy restrain the market growth. The development of novel therapeutic drugs with improved efficacy offers lucrative opportunities in the market. Key players are focusing on R&D to develop advanced treatment regimens for tackling drug resistance issues. However, stringent regulations for approval of new allergy drugs pose a challenge

Key Features of the Study:

• This report provides an in-depth analysis of the global allergy treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global allergy treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global allergy treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.

Detailed Segmentation-

• By Type:
  • Eye Allergy
  • Asthma
  • Rhinitis
  • Skin Allergy
  • Food Allergies
  • Others
• By Treatment:
  • Anti-allergy Drugs
  • Immunotherapy
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Sanofi
  • Novartis
  • GSK plc
  • Johnson & Johnson Services, Inc.
  • Hoffmann-La Roche Ltd.
  • Stallergenes Greer
  • Dermapharm Holding SE
  • Nicox
  • Allergy Therapeutics
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Alembic Pharmaceuticals Limited
  • ALK-Abello A/S
  • Bausch Health Companies Inc.
  • GLENMARK PHARMACEUTICALS LTD.
  • Perrigo Company plc
  • Dr Reddy's Laboratories Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Treatment
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Epidemiology
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Allergy Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Allergy Treatment Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Eye Allergy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Asthma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rhinitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Skin Allergy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Food Allergies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Allergy Treatment Market, By Treatment, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Anti-allergy Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Allergy Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Allergy Treatment Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stallergenes Greer
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dermapharm Holding SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nicox
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Allergy Therapeutics
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Alembic Pharmaceuticals Limited
  • ALK-Abello A/S
  • Bausch Health Companies Inc.
  • GLENMARK PHARMACEUTICALS LTD.
  • Perrigo Company plc
  • Dr Reddy's Laboratories Ltd.

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact